ETHOMOXANE, (-)-

Details

Stereochemistry	UNKNOWN
Molecular Formula	C15H23NO3
Molecular Weight	265.348
Optical Activity	( - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CCCCNCC1COC2=C(O1)C(OCC)=CC=C2

InChI

InChIKey=WKRAEDUMAWVCOC-UHFFFAOYSA-N

InChI=1S/C15H23NO3/c1-3-5-9-16-10-12-11-18-14-8-6-7-13(17-4-2)15(14)19-12/h6-8,12,16H,3-5,9-11H2,1-2H3

HIDE SMILES / InChI

Molecular Formula	C15H23NO3
Molecular Weight	265.348
Charge	0
Count

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Description
Sources: https://books.google.de/books?id=xUlaDwAAQBAJ&printsec=frontcover&hl=ru#v=onepage&q&f=false | https://www.ncbi.nlm.nih.gov/pubmed/6106536

Ethomoxane is antagonist of alpha-adrenoreceptor exerting antihypertensive properties.

Approval Year

PubMed

Title	Date	PubMed
Furter investigations on the interaction between alpha-adrenoceptor antagonists and the central hypotensive effect of clonidine in rats, rabbits and dogs.	1980 Jul	6106536

Patents

Substance Class	Chemical Created by `admin` on `Sat Dec 16 18:22:56 GMT 2023` Edited by `admin` on `Sat Dec 16 18:22:56 GMT 2023`
Record UNII	QA4CFB5IF8
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ETHOMOXANE, (-)-

Common Name

English

1,4-BENZODIOXIN-2-METHANAMINE, N-BUTYL-8-ETHOXY-2,3-DIHYDRO-, (-)-

Systematic Name

English

Code System Code Type Description

FDA UNII

QA4CFB5IF8

Created by admin on Sat Dec 16 18:22:57 GMT 2023 , Edited by admin on Sat Dec 16 18:22:57 GMT 2023

PRIMARY

CAS

793603-27-7

Created by admin on Sat Dec 16 18:22:57 GMT 2023 , Edited by admin on Sat Dec 16 18:22:57 GMT 2023

PRIMARY

Related Record Type Details


					5F53O2A6GE

ETHOMOXANE

RACEMATE -> ENANTIOMER


					8FSZ8H38N1

ETHOMOXANE, (+)-

ENANTIOMER -> ENANTIOMER

Amount: